RECRUITING

Azithromycin Before Induction

Description

This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

Conditions

Infections
Talk to us

Related Conditions:

Infections

Study Overview

On this page

Study Details

Study overview

This is a double blinded randomized control trial involving administration of 2 grams prophylactic azithromycin in third trimester patients undergoing induction of labor at our institution to demonstrate reduction in maternal and neonatal infection.

Azithromycin to Prevent Chorioamnionitis in Women Undergoing Induction of Labor, a Randomized Control Trial

Azithromycin Before Induction

Condition
Infections
Intervention / Treatment

-

Contacts and Locations

Colton

Arrowhead Regional Medical Center, Colton, California, United States, 92324

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * • Third trimester of pregnancy defined as 28 0/7 weeks or more
  • * Singleton pregnancy
  • * Age 18-45
  • * Induction of labor initiated for medical or obstetrical reason or electively over 39 weeks of gestation
  • * No contraindication to vaginal delivery
  • * Reassuring fetal heart rate tracing
  • * Able and willing to provide informed consent
  • * • Does not read or write in English or Spanish
  • * Unable or unwilling to give informed consent
  • * Use of antibiotic or antiviral agent within the last 7 days
  • * Evidence of active infection at the time of initiation of induction (patients with rectovaginal group B streptococcus positive results will be allowed to participate as it is a colonizing organism, unless they show evidence of active infection)
  • * Incarcerated Women
  • * Active substance abuse
  • * Age \< 18

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Arrowhead Regional Medical Center,

Study Record Dates

2025-08-07